RF
AGL icon

Rubicon Founders’s Agilon Health AGL Stock Holding History

Rubicon Founders’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
105,341
-146,354
-58% -$9.59M 5.75% 3
2026
Q1 		$1.99M Sell
251,695
-1
-0% -$16 1.45% 3
2025
Q4 		$4.33M Hold
251,696
– – 2.63% 3
2025
Q3 		$6.48M Hold
251,696
– – 3.25% 3
2025
Q2 		$14.5M Buy
251,696
+4,085
+2% +$328K 6.8% 3
2025
Q1 		$26.8M Buy
+247,611
New +$21.6M 16.48% 2

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rubicon Founders's AGL Position: Q2 2026 in Review

Rubicon Founders reduced its Agilon Health (AGL) stake by 58% in Q2 2026, selling an estimated $9.59M and leaving 105,341 shares worth $11.3M. The position accounts for 5.75% of the portfolio, ranked #3.

Rubicon Founders first reported a position in AGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.8M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Rubicon Founders held 105,341 shares of Agilon Health worth $11.3M as of Q2 2026.
  • Rubicon Founders sold 146,354 Agilon Health shares in Q2 2026, an estimated $9.59M.
  • Agilon Health made up 5.75% of Rubicon Founders's portfolio in Q2 2026, its #3 holding.
  • Rubicon Founders first reported a position in Agilon Health in Q1 2025 and has held it in 6 quarters since.
  • Rubicon Founders's Agilon Health position peaked at $26.8M in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Rubicon Founders's 13F filing for Q2 2026, filed 14 Aug 2026.